Novel and specific inhibitors of a poxvirus type I topoisomerase

Alexis Bond1, Zachary Reichert, James T Stivers

  • 1Department of Pharmacology and Molecular Sciences, The Johns Hopkins University, School of Medicine, Baltimore, MD 21205-2185, USA.

Molecular Pharmacology
|November 4, 2005
PubMed

Insights

Researchers identified novel small-molecule inhibitors targeting vaccinia DNA topoisomerase (vTopo), crucial for viral replication. These compounds are highly specific for vTopo, showing no inhibition against the human enzyme, offering potential therapeutic avenues.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Virology

Background:

  • Vaccinia DNA topoisomerase (vTopo) is essential for poxvirus replication and shares similarities with human topoisomerase I (hTopo).
  • Despite structural similarities, vTopo and hTopo exhibit distinct pharmacological profiles, presenting an opportunity for targeted drug development.

Purpose of the Study:

  • To develop and implement a high-throughput screening (HTS) assay for identifying vTopo inhibitors.
  • To characterize novel small-molecule inhibitors that selectively target vTopo over hTopo.

Main Methods:

  • A high-throughput screen of a 1990-member small-molecule library was conducted against vTopo.
  • Inhibitory activity was assessed by measuring DNA supercoil relaxation.
  • Potent inhibitors were further characterized using various biochemical assays to determine their mechanism of action and specificity.

Main Results:

  • The HTS identified 21 compounds with IC(90) values below 10 muM, with 19 inhibiting vTopo DNA supercoil relaxation.
  • Four novel, potent vTopo inhibitors were characterized, demonstrating nanomolar efficacy.
  • These inhibitors exhibited high specificity for vTopo, with no observed inhibition of hTopo even at significantly higher concentrations (500- to 2000-fold).

Conclusions:

  • Novel, highly specific vTopo inhibitors have been discovered using a new HTS assay.
  • These compounds represent promising leads for antiviral therapies targeting poxviruses.
  • The study highlights the distinct pharmacological properties of vTopo and its susceptibility to diverse small-molecule inhibitors.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...